A phase I study of the safety and immunogenicity of a therapeutic vaccine, DPX-0907 in patients with advanced-stage ovarian, breast, or prostate cancer.
N. L. Berinstein
Consultant or Advisory Role - Immunovaccine
M. Morse
No relevant relationships to disclose
H. Kaufman
No relevant relationships to disclose
J. J. Nemunaitis
No relevant relationships to disclose
K. Odunsi
No relevant relationships to disclose
G. S. Chatta
No relevant relationships to disclose
G. Weir
Employment or Leadership Position - Immunovaccine
L. MacDonald
Employment or Leadership Position - Immunovaccine
M. Stanford
Employment or Leadership Position - Immunovaccine
M. Karkada
Employment or Leadership Position - Immunovaccine
R. Nigam
Employment or Leadership Position - Immunovaccine
M. Mansour
Employment or Leadership Position - Immunovaccine
Stock Ownership - Immunovaccine